Activity of sera from patients with Lyme disease against Borrelia burgdorferi

Clinical Infectious Diseases

Volumn 25, Issue 1 SUPPL., 1997, Pages

  Pavia, Charles S ^a   Wormser, Gary P ^b   Norman, Gary L ^b  

^a NEW YORK INSTITUTE OF TECHNOLOGY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; BACTERICIDAL ACTIVITY; BORRELIA BURGDORFERI; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LYME DISEASE; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; PROTECTION; SERUM;

EID: 0030744144     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/516168     Document Type: Conference Paper

References (15)

1. Steere AC. Lyme disease. N Engl J Med 1989;321:586-93.
2. Barthold SW. Lyme borreliosis in the laboratory mouse. Journal of Spirochetal Vector-Borne Diseases 1996;3:22-44.
3. Benach JL, Bosler EM, Hanrahan JP, et al. Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med 1983;308: 740-2.
4. Nadelman RB, Pavia CS, Magnarelli LA, Wormser GP. Isolation of Borrelia burgdorferi from the blood of seven patients with Lyme disease. Am J Med 1990;88:21-6.
5. Johnson RC, Kodner C, Russell M. Active immunization of hamsters against experimental infection with Borrelia burgdorferi. Infect Immun 1986;54:897-8.
6. Fikrig E, Barthold SW, Kantor FS, Flavell RA. Protection of mice against the Lyme disease agent by immunizing with recombinant OspA. Science 1990;250:553-6.
7. Schmitz JL, Schell RF, Hejka AG, England DM. Passive immunization prevents induction of Lyme arthritis in LSH hamsters. Infect Immun 1990;58:144-8.
8. Barthold SW, Bockenstedt LK. Passive immunizing activity of sera from mice infected with Borrelia burgdorferi. Infect Immun 1993;61:4696-702.
9. Fikrig E, Bockenstedt LK, Barthold SW, et al. Sera from patients with chronic Lyme disease protect mice from Lyme borreliosis. J Infect Dis 1994;169:568-74.
10. Pavia CS, Kissel V, Bittker S, Cabello F, Levine S. Antiborrelial activity of serum from rats injected with the Lyme disease spirochete. J Infect Dis 1991;163:656-9.
11. Callister SM, Jobe DA, Schell RF, Pavia CS, Lovrich SD. Sensitivity and specificity of the borreliacidal antibody test during early Lyme disease: a gold standard. Clin Diag Lab Immunol 1996;3:399-402.
12. Centers for Disease Control. Case definitions for public health surveillance. MMWR Morb Mortal Wkly Rep 1990;39(RR-13):1-43.
13. Norman GL, Antig JM, Bigaignon G, Hogrefe W. Serodiagnosis of Lyme borreliosis by Borrelia burgdorferi sensu stricto, B. garinii, and B. afzelii western blots (immunoblots). J Clin Microbiol 1996;34:1732-8.
14. Aguero-Rosenfeld ME, Nowakowski J, Bittker S, et al. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol 1996; 34:1-9.
15. Dressler F, Whalen JA, Reinhardt BN, Steere AC. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis 1993;167: 392-400.